Ed Geistlich S��hne AG F��r Chemische Industrie is a multi-national private company headquartered in Schlieren, Switzerland. The firm operates as holding company.

Micap Ltd. manufacturs microscopic capsules. It provides encapsulation\nand formulation services from consultancy to manufacture for the food, agrochemical and pharmaceutical industries from probiotics to speciality chemicals. Its services includes consultancy, product design and process development. It is located in Wigan, United Kingdom

SeLux Diagnostics, Inc. develops universal synthetic amplifier technology equipment. The firm offers Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. The company was founded by Eric Stern and Aleksander Vacic in 2014 and is headquartered in Charlestown, MA.

T2 Biosystems, Inc. engages in the development of a proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables detection of pathogens, biomarkers, and other abnormalities in a range of unpurified patient sample types. The firm's products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

Provides fully integrated contract manufacturing services to medical device manufacturers worldwide in the cardiovascular, endoscopy and orthopedic markets

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Manufactures and sells pharmaceuticals

Manufactures chemicals, pharmaceuticals and metals

Novexel is a pharmaceutical company that researches and develops novel class antiinfectives for the treatment of severe and difficult to treat bacterial and fungal infections. The Company has an extensive portfolio of antibacterial and anti-fungal compounds, R&D programs, and intellectual property. Novexel’s focus is on novel antimicrobial compounds with activity against multi-resistantorganisms. Novexel’s expertise in Biology, Medicinal Chemistry, Pharmacology, Microbiology and Clinical Development positions the Company at the forefront of the discovery and development of novel therapies for infectious disease.

Fuan Pharmaceutical is a medicine production company. Their products include etimicin sulfate, sodium valproate, piracetam, lenvatinib mesylate, ornidazole, avibactam, tofacitinib citrate, midazolam, thioctic acid, ezetimibe, repaglinide, lercanidipine hydrochloride, aripiprazole, and cefazolin sodium.

Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd., established on 1996-04-24, Business scope includes licensed projects:Disinfectant production(Free of Hazardous Chemicals);pharmaceutical production;Pharmaceutical commissioned production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).General project:Medical Technology Development,Technical Services,technical consulting,technology transfer;Import and export of goods and technology.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]Production of small volume injections,large volume injection,powder injection(Contains cephalosporins),tablet(Contains anti-tumor),hard capsule(Contains anti-tumor),Granules,Powder,inhalation solution,powder injection(Penicillins),small volume injection(extract)(Engage in business according to the items and time limit approved by the license).**.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Astra Zeneca Holding France SAS operates as a holding firm with interest in pharmaceuticals. The company was founded in 1994 and is headquartered in Rueil-Malmaison, France.

The Hyundai Motor Company is a South Korean multinational automotive manufacturer. It has various vehicle lineups, brand vision, and global campaigns like clean mobility, sustainability, art, and sports partnership. The company was founded in 1967 and, along with its 32.8% owned subsidiary, Kia Motors, together comprise the Hyundai Motor Group, which is the world's fifth-largest automaker based on annual vehicle sales in 2012. In 2008, Hyundai Motor (without Kia) was ranked as the eighth largest automaker. As of 2012, the company sold over 4.4 million vehicles worldwide in that year, and together with Kia total sales were 7.12 million.

Sichuan Wanger Agricultural Technology Co., Ltd., established on 2015-11-23, Business scope includes technological development in the field of agriculture,technology transfer,technical consulting,Technical Services;oil crop planting,Sales;forest product processing,Sales;Tree nursery(Does not contain tree seeds);flower planting;Chinese herbal medicine planting,Sales;livestock,Aquaculture,Sales;Forestry tourism project development;Landscaping engineering design and construction.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

KPC is a pharmaceutical company that engages in the manufacture of pharmaceuticals. Tablets, fluids, ointments, and injectables are among their offerings. Its goal is to improve people's lives by enabling them to achieve more, feel better, and live longer. They have technological machinery, skilled and motivated individuals, and management systems that can handle both quantity and quality of work. They are looking for new ways to improve their performance, raise their integrity to a level of excellence, implement their initiatives, and achieve their goals.

Changshu Jinshen Medical Products Co. Ltd. is a private company headquartered in Suzhou, China, that provides medical products.

Shandong Freda Pharmaceutical Group Co. Ltd., a subsidiary of Province of Shandong, is a company headquartered in China. The firm manufactures pharmaceutical products. It was acquired by Lushang Freda Pharmaceutical Co., Ltd. from Shandong Commercial Group Co., Ltd. on December 31, 2018 for $153.09 million.

Porton Pharma Solutions Ltd. engages in the research, development and manufacture of pharmaceutical products and active pharmaceutical ingredients. It offers anti-viral, anti-diabetic, anti-hypertensive, anti-cancer, analgesic, hypolipidemic, and antibacterial drug treatment. The company was founded on July 7, 2005 and is headquartered in Chongqing, China.

Kia Motors Corporation, commonly known as Kia Motors.(Korean: 기아자동차; Hanja: 起亞自動車, IPA: [ki.a], lit. "Kia automobile"; stylized as KIɅ), headquartered in Seoul, is South Korea's second-largest automobile manufacturer, following the Hyundai Motor Company, with sales of over 3.3 million vehicles in 2015. As of December 2015, the Kia Motor Corporation is minority owned by Hyundai, which owns a 33.88% stake valued at just over US$6 billion. Kia in turn is a minority owner of more than twenty Hyundai subsidiaries ranging from 4.9% up to 45.37%, totaling more than US$8.3 billion.